Kathleen E. Hamilton

Kathleen Hamilton serves as a key procurement lead within the W4PZ USA Medical Research Acquisition Act under the Department of the Army, driving the acquisition of advanced biomedical capabilities to enhance warfighter health and operational readiness. She manages a diverse portfolio of research and development contracts focused on translating laboratory innovations into field-deployable medical solutions, including therapeutic agents, diagnostic platforms, and life sciences technologies. Her work is central to the agency’s mission of accelerating translational medical research, ensuring that cutting-edge scientific discoveries are rapidly integrated into military healthcare systems through agile, performance-based contracting approaches. Her contractor relationships span high-capability research institutions, biotechnology firms, and specialized consulting providers, with consistent engagement with small businesses that bring niche expertise in biological manufacturing and clinical diagnostics. She fosters collaborative partnerships with vendors capable of meeting stringent DoD compliance standards, particularly those with experience in GMP production, biosafety level 3 operations, and rapid prototyping of medical countermeasures. Her procurement style emphasizes technical rigor, innovation scalability, and vendor accountability across the product development lifecycle. Hamilton demonstrates a strong commitment to socioeconomic diversity in contracting, with a pronounced preference for small business set-asides—nearly 55% of her acquisitions are reserved for small businesses, including 36.4% under Total Small Business Set-Aside and 18.2% allocated to HUBZone firms. This reflects a deliberate strategy to cultivate a resilient, agile supplier base capable of responding to urgent medical readiness needs. Her primary procurement focus lies in NAICS 325414 (Biological Product Manufacturing), 541620 and 541690 (Scientific and Technical Consulting), and 541715 (Life Sciences R&D), reflecting deep expertise in procuring novel therapeutics, diagnostic tools, and analytical platforms. She consistently sources solutions that bridge the gap between academic research and operational deployment in austere environments.